FROM 01 Dec Myfortic will be
listed on the Pharmaceutical
Benefits Scheme for Australians
living with lupus nephritis.
The approval provides a
treatment option for up to 2,000
Australians with this potentially life
threatening kidney disorder (which
causes inflammation of the kidney
and can result in mild, moderate or
severe kidney damage).
“I think this is a great outcome for
patients with lupus nephritis,” said
Dr Richard Phoon, Senior Staff
Specialist in Nephrology at
Westmead Hospital.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Nov 12
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.